Concepedia

Shifeng Xu

SX

Statistics

Publications

15

Citations

795

H-Index

12

Active since

2010

Affiliations

Shandong Provincial Hospital(Current)

Shandong University

Qingdao University

Affiliated Hospital of Qingdao University

Shandong First Medical University

Shifeng Xu is an author at Shandong Provincial Hospital specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2010–2022

15

Publications

15

TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway

Guohe Song, Shifeng Xu, Hong Zhang et al. · Journal of Experimental & Clinical Cancer Research · 2016 · 375 citations · Full text

, , +17

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Liqun Wu, Herui Yao, Hui Chen et al. · Nature Communications · 2022 · 126 citations · Full text

, , +17

Hepatitis B virus X protein upregulates transcriptional activation of human telomerase reverse transcriptase

Hua Liu, Fang Luan, Shifeng Xu et al. · Virus Genes · 2010 · 45 citations

, , +14

Long noncoding RNA CASC21 exerts an oncogenic role in colorectal cancer through regulating miR-7-5p/YAP1 axis

Yuanwen Zheng, Peihua Nie, Shifeng Xu · Biomedicine & Pharmacotherapy · 2019 · 35 citations · Full text

, , +17

Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma

Tao Li, Yuhua Zhu, Chengyong Qin et al. · Journal of Clinical Pathology · 2012 · 28 citations

, , +17

1–5 of 15